对母亲和婴儿单剂量尼维拉平治疗方案的成本效益,以减少撒哈拉以南非洲的垂直HIV-1传播
E Marseille1, J G Kahn, F Mmiro
1Health Strategies International, Orinda, CA 94563, USA. emarseille@home.com
Lancet (London, England)
|September 15, 1999
概括
在撒哈拉以南非洲,HIVNET 012尼维拉平治疗方案是一种具有成本效益的干预措施,以减少母婴HIV-1传播. 这一战略以合理的成本提供了显著的公共卫生效益,特别是在高HIV-1血清流行地区.
科学领域:
- 公共卫生 公共卫生
- 传染病流行病学 传染病流行病学
- 卫生经济学 卫生经济学
背景情况:
- 减少儿科人类免疫缺陷病毒1型 (HIV-1) 传播是撒哈拉以南非洲的一个关键公共卫生挑战.
- 迫切需要采取经济干预措施,以防止艾滋病毒-1从母亲传播给儿童.
研究的目的:
- 为了评估HIVNET 012nevirapine治疗方案的成本效益,以预防儿科HIV-1传播.
- 将HIVNET 012疗法与其他短期抗逆转录病毒疗法进行比较.
- 评估两个实施策略:有针对性的治疗与普遍治疗.
主要方法:
- 模拟了撒哈拉以南非洲2万名孕妇的假设队列.
- 关键结果包括计划成本,避免了儿科HIV-1病例,避免了每病例的成本,以及每残疾调整寿命年 (DALY) 的成本.
- 进行了敏感性分析,以评估研究结果的可靠性.
主要成果:
- 全民HIVNET 012治疗30%的HIV-1血清流行率避免了603例病例,每例138美元.
- 针对30%血清流行率的向治疗避免了476例病例,每例病例避免费用为298美元.
- 与其他公共卫生干预相比,当血清流行率超过3.0% (普遍) 或4.5% (向) 时,该疗法具有成本效益.
结论:
- 在艾滋病毒-1血清流行率较高的环境中,HIVNET 012疗法表现出高的成本效益.
- 尼维拉平治疗可以以合理的成本显著影响公众健康,特别是在血清流行率较低的地区,其他多剂量疗法可能不具有成本效益.
相关概念视频
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...


